Research Topics
| htlv ii antibodiesSummarySummary: Antibodies reactive with the HTLV-II ANTIGENS. Top Publications
| Scientific Experts
|
Detail Information
Publications
Effectiveness of human T-lymphotropic virus (HTLV) recipient tracing (lookback) and the current HTLV-I and -II confirmatory algorithm, 1999 to 2004S L Stramer
American Red Cross, Biomedical Services Scientific Support Office, Gaithersburg, Maryland 20877, USA
Transfusion 46:703-7. 2006..This study reports on the efficacy of an investigational human T-lymphotropic virus (HTLV)-I and -II lookback program in the context of differing confirmatory testing algorithms...- Molecular characterization of human T-cell lymphotropic virus type 2 (HTLV-II) from people living in urban areas of Sao Paulo city: evidence of multiple subtypes circulationPatricia Novoa
Institute of Infectious Diseases Emilio Ribas, Sao Paulo, Brazil
J Med Virol 79:182-7. 2007..This is the first time HTLV-II subtype b has been described in Brazil. However, further studies, such as a complete nucleotide DNA sequencing, need to be done to confirm these findings... - Is seroprevalence of HTLV-I/II among blood donors in India relevant?Harsh Kumar
Department of Transfusion Medicine, Armed Forces Medical College, Pune 411 040
Indian J Pathol Microbiol 49:532-4. 2006..The prevalence of HTLV-I/II carriers in India seems to be negligible and is not a major public health hazard. Hence, routine screening of Indian blood donors for antibody to HTLV-I/II is not warranted due to its low prevalence in India... - HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlatesLuis de la Fuente
Centro Nacional de Epidemiologia, Instituto de Salud Carlos III, C Sinesio Delgado 6, 28029 Madrid, Spain
J Clin Virol 35:244-9. 2006.... - HTLV-1 infection is frequent among out-patients with pulmonary tuberculosis in northern Lima, PeruK Verdonck
Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru
Int J Tuberc Lung Dis 11:1066-72. 2007..Tuberculosis (TB) and human T-lymphotropic virus 1 (HTLV-1) are frequent in Peru. The prevalence of HTLV-1 among Peruvian TB patients is unknown... - Prevalence and molecular characterization of human T cell leukemia virus type 2 in a group of intravenous drug users coinfected with HIV type 1 in PortugalAna Filipa Silva
, , P-1649-016 Lisbon, Portugal
AIDS Res Hum Retroviruses 21:249-55. 2005.... - High prevalence of HTLV-I and HTLV-II among blood donors in Argentina: a South American health concernMirna M Biglione
Centro Nacional de Referencia para el SIDA (CNRS, , Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina
AIDS Res Hum Retroviruses 21:1-4. 2005..01%) were born in HTLV-I/II South American endemic areas. Although Argentina has been considered a nonendemic country for HTLV-I/II, the need for systematic screening for such infection became imperative based on the present study... - Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): serological screening prevalence rates in blood donors from large urban areas in BrazilBernadette Catalan-Soares
Fundação Hemominas, Belo Horizonte, Brazil
Cad Saude Publica 21:926-31. 2005..0/1,000 in São Luiz, Maranhão State, in the Northeast. EIA prevalence rates are lower in the South and higher in the North and Northeast. The reasons for such heterogeneity may be multiple and need further studies... - Low prevalence of antibodies to human T-lymphotropic virus-I/II among blood donors in eastern Saudi ArabiaNaglaa A Fawaz
Department of Hematology, King Faisal University, Damman, Saudi Arabia
Am J Infect Control 33:189-91. 2005..Although the very low prevalence of HTLV-I/II among Saudi donors does not support routine screening, screening of donors from other nationalities may be initiated, especially those from HTLV-I/II endemic areas... - Unusually high incidence of positive HTLV I/II results among young female organ donors in the peripartum periodErnesto P Molmenti
Baylor University Medical Center, Transplantation Services, Dallas, Texas 75246, USA
Dig Dis Sci 47:2383-5. 2002..Further confirmatory tests may be difficult to obtain because of time and economic constraints associated with organ procurement... 
Serological patterns and temporal trends of HTLV-1/2 infection in high-risk populations attending Public Health Units in São Paulo, BrazilFabrício Jacob
Immunology Department, Instituto Adolfo Lutz, Av Dr Arnaldo 355, 11 andar, 01246 902 São Paulo, SP, Brazil
J Clin Virol 42:149-55. 2008..HTLV-1/2 diagnosis in high-risk populations from São Paulo, Brazil has been problematic due a high proportion of seroindeterminate results...- [HTLV 1/2 infection: prenatal performance as a disease control strategy in State of Mato Grosso do Sul]Márcia Maria Ferrairo Janini Dal Fabbro
Instituto de Pesquisas, Ensino e Diagnósticos, Associação de Pais e Amigos dos Excepcionais de Campo Grande, Campo Grande, MS
Rev Soc Bras Med Trop 41:148-51. 2008..Comorbidities were found in 17% (26/153), among whom 3.3% (5/153) had HIV (p<0.000002). The authors emphasize the importance of identifying pregnant women with HTLV 1/2 infection, as a strategy for disease control and prevention... - Evaluation of surrogate markers for human immunodeficiency virus infection among blood donors at the blood bank of "Hospital Universitário Regional Norte do Paraná", Londrina, PR, BrazilEdna Maria Vissoci Reiche
Departamento de Patologia Aplicada, Legislação e Deontologia, Centro de Ciencias da Saude, Universidade Estadual de Londrina, Londrina, PR, Brasil
Rev Inst Med Trop Sao Paulo 45:23-7. 2003.... 
Post-transplantation HTLV-1 myelopathy in three recipients from a single donorJ J Zarranz Imirizaldu
Department of Neurology, Hospital of Cruces, s/n CP 48903 Baracaldo, Vizcaya, Spain
J Neurol Neurosurg Psychiatry 74:1080-4. 2003....- [Sero-epidemiological study on the human T-cell leukaemia virus type I/II infection in the east coastal areas of Fujian province]Hui rong Wang
Fujian Province Center for Disease Control and Prevention, Fuzhou 350001, China
Zhonghua Liu Xing Bing Xue Za Zhi 25:428-30. 2004..The seroprevalence of HTLV-I was very low, with no HTLV-II. Neither age nor gender seemed to be HTLV-I risk factor in the east coastal areas of Fujian province, but the increase of exposure to sex might be one... - Seroprevalence and molecular epidemiology of human T-Cell leukemia virus type 1 (HTLV-1) and HTLV-2 in blood donors from Dakar, SenegalSaliou Diop
, , Batiment Lwoff, Institut Pasteur, 25 28 Rue du Dr Roux, 75724 Paris, Cedex 15, France
J Clin Microbiol 44:1550-4. 2006..These data highlight the problem of transfusion safety in this area where HTLV-1-associated lymphoproliferative and neurological diseases are endemic... - Prevalence of human T-lymphotropic virus type I and type II antibody among blood donors in Eastern Saudi ArabiaZahoor Ul-Hassan
Department of Laboratory and Blood Bank, King Fahad Hospital and Tertiary Care Center, Al-Hofuf, Al-Hasa, Kingdom of Saudi Arabia
Saudi Med J 25:1419-22. 2004..CONCLUSION: Al-Hasa region is non-endemic for HTLV-I/II virus infections. Screening of native Saudi blood donors for these viruses does not appear to be cost effective... - Human T-cell lymphotropic virus type II in Guaraní Indians, Southern BrazilMarcio Menna-Barreto
Hospital Sao Lucas, Pontificia Universidade Catolica do Rio Grande do Sul, Porto Alegre, Brasil
Cad Saude Publica 21:1947-51. 2005..76%) showed positive anti-HTLV-II antibodies (enzyme-linked immunosorbent assay and Western blot). This preliminary report is the first seroepidemiological study showing HTLV-II infection among Indians in the South of Brazil... - Human T lymphotropic virus types I and II western blot seroindeterminate status and its association with exposure to prototype HTLV-IKaren Yao
Viral Immunology Section, Neuroimmunology Branch, National Institute of Neurologic Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA
J Infect Dis 193:427-37. 2006..Our findings warrant further investigation of the possible clinical outcomes associated with WB seroindeterminate status... - The seroepidemiology of human T-lymphotropic viruses: types I and II in Europe: a prospective study of pregnant womenGraham P Taylor
Faculty of Medicine, Wright Fleming Institute, Imperial College, Norfolk Place, London, United Kingdom
J Acquir Immune Defic Syndr 38:104-9. 2005..Most data on the seroprevalence of HTLV-I and HTLV-II in Europe are from studies of low-risk blood donors or high-risk injection drug users (IDUs). Little is known about the general population... - HTLV-2 horizontal and vertical transmission in a family from a Brazilian urban area: seroepidemiological, clinical and molecular studyBernadette Catalan-Soares
Fundação Centro de Hematologia e Hemoterapia de Minas Gerais Hemominas, Minas Gerais, Brazil
AIDS Res Hum Retroviruses 21:521-6. 2005..Analyzing both LTR and env regions, the family's sequences clustered with isolates of Brazilian intravenous drug users and transfusion transmitted virus... - Seroprevalence of human T cell leukemia virus in HIV antibody-negative populations in rural CameroonAna Machuca
Division Diagnosticos, Quimica Farmaceutica Bayer, Madrid, Spain
Clin Infect Dis 40:1673-6. 2005..Of the 88 serum samples that the enzyme immunoassay found to be repeatedly reactive, the HTLV status of 49 samples was confirmed by Western blot assay to be HTLV type I, and the status of 6 samples was confirmed to be HTLV type II... - Prevalence of HIV-1 non-B subtypes, syphilis, HTLV, and hepatitis B and C viruses among immigrant sex workers in Madrid, SpainMaite Gutiérrez
Microbiology Unit, Hospital Carlos III, Madrid, Spain
J Med Virol 74:521-7. 2004..A relatively high proportion of immigrant sex workers in Madrid were infected with HIV-1 and syphilis, whereas infections with hepatitis viruses or HTLV were uncommon... - Molecular evidence for infection by HTLV-2 among individuals with negative serological screening tests for HTLV antibodiesR Ishak
Laboratorio de Virologia, Centro de Ciencias Biologicas, Universidade Federal do Para, Belem, Para, Brasil
Epidemiol Infect 135:604-9. 2007.... - High seroprevalence of anti-HTLV-I/II antibodies among solid organ donors necessitates confirmatory testingMarek J Nowicki
National Institute of Transplantation, Los Angeles, CA 90057, USA
Transplantation 82:1210-3. 2006..Confirmatory testing is not routinely performed, and the number of false positive organ donors is unknown... - Geographic distribution of human T-lymphotropic virus types 1 and 2 among mothers of newborns tested during neonatal screening, Minas Gerais, BrazilMaísa Aparecida Ribeiro
Fundação Hemominas, Belo Horizonte, Minas Gerais, Brazil
Rev Panam Salud Publica 27:330-7. 2010.... - [Prevalence, risk factors and genetic characterization of human T-cell lymphotropic virus types 1 and 2 in patients infected with human immunodeficiency virus type 1 in the cities of Ribeirão Preto and São Paulo]Walter Kleine Neto
Fundação Pró Sangue, Hemocentro de São Paulo, Av Dr Enéas Carvalho de Aguiar 155, Sao Paulo, SP
Rev Soc Bras Med Trop 42:264-70. 2009..Among the 12 HTLV type 2 samples, seven were from injected drug users, thus indicating that this route is an important risk factor for HTLV type 2 transmission among our population infected with HIV type 1... - Epidemiology of human T-cell lymphotropic virus type 1 infection in blood donors, IsraelShmuel Stienlauf
Sheba Medical Center, Tel Hashomer, Israel
Emerg Infect Dis 15:1116-8. 2009..In donors originating from Eastern Europe, the Middle East, and Latin America, prevalences are 7.7, 14.6, and 20.4, respectively. HTLV-1 prevalence may be high outside areas where HTLV-1 previously was known to be endemic... - Confirming the presence of HTLV-1 infection and the absence of HTLV-2 in blood donors from Arequipa, PeruNadia Carmela Santos Quispe
Hospital Goyeneche, Arequipa, Peru
Rev Inst Med Trop Sao Paulo 51:25-9. 2009.... - Seroprevalence of human T lymphtropic virus (HTLV) among tissue donors in Iranian tissue bankBabak Arjmand
Iranian Tissue Bank Research and Preparation Center and Brain and Spinal Injury Repair Research Center, Tehran University of Medical Sciences, Imam Khomeini Hospital, Keshavarz Blvd, Tehran, Iran
Cell Tissue Bank 10:247-52. 2009.... - Seroprevalence of human T-lymphotropic virus type 1 and 2 in Korean blood donorsSo Yong Kwon
Blood Transfusion Research Institute, Korean Red Cross, Seoul, Korea
J Med Virol 80:1864-7. 2008..007%. Based on the results of this study, an extended study will be conducted to evaluate whether introduction of HTLV screening is necessary in Korea... - Evaluation of a new, fully automated immunoassay for detection of HTLV-I and HTLV-II antibodiesXiaoxing Qiu
Abbott Diagnostics, AIDS Research and Retrovirus Discovery, Abbott Park, Illinois 60064 6015, USA
J Med Virol 80:484-93. 2008..6) populations. Based on the excellent specificity and sensitivity, the new ARCHITECT rHTLV-I/II assay should be an effective test for the diagnosis of HTLV-I/II infection and also for blood donor screening... - Performances of HTLV serological tests in diagnosing HTLV infection in high-risk population of São Paulo, BrazilFabrício Jacob
Seção de Imunologia, Instituto Adolfo Lutz, Sao Paulo, SP, Brasil
Rev Inst Med Trop Sao Paulo 49:361-4. 2007.... - Comparison of four commercial screening assays for the diagnosis of human T-cell lymphotropic virus types 1 and 2Carolina A Berini
Centro Nacional de Referencia para el SIDA, Departamento de Microbiologia, Parasitología e Immunología, Facultad de Medicina, Universidad de Buenos Aires, Paraguay 2155, Piso 11, C1121ABG Buenos Aires, Argentina
J Virol Methods 147:322-7. 2008..These results should be considered for choosing the most accurate serological screening assays in order to obtain an optimal efficiency of the current algorithm for HTLV-1/2 diagnosis... - Serologial screening of human T cell lymphotropic virus I and II (HTLV I/II) in blood banks by immunoblotting and enzyme-immuno assays: to demand or to defeat?Maha I Sh Kawashti
Microbiology and Immunology Department, Faculty of Medicine for Girls, AI Azhar University, Cairo, Egypt
Egypt J Immunol 12:137-42. 2005..As screening for HTLV I/II is still mandatory, it could be done on pools of sera rather than on individual serum samples, after standardization of a pooling protocol, to fulfill coast-effectiveness and reduce the coasts by 90-95%... - [Evaluation of new fourth-generation human immunodeficiency virus antigen and antibody detection assay with enzyme-linked fluorescent immunoassay]Takako Shima
Department of Biology, Kanagawa Prefectural Institute of Public Health
Kansenshogaku Zasshi 81:562-72. 2007..DUOII has sufficient specificity and sensitivity for HIV screening, and detects primary infection sooner than other assays. These results indicate that DUOII is useful and reliable in HIV screening... - Unusual finding of HTLV-I infection among Amazonian AmerindiansLuis Isamu Barros Kanzaki
Laboratory of Molecular Pharmacology, Faculty of Health Sciences, University of Brasilia, Brasilia, DF, Brazil
Arch Med Res 38:897-900. 2007..Also, the very low prevalence of HTLV type I infection among these ethnic groups probably indicates contamination by blood transfusion (external transmission route)... - Hospital-based surveillance for HTLV-1/2 infections in SpainCarlos Toro
Service of Infectious Diseases, Hospital Carlos III, Madrid, Spain
AIDS Res Hum Retroviruses 23:1075-7. 2007..However, a rapidly growing population of immigrants from HTLV-1-endemic areas in Spain could modify this pattern and periodic surveillance studies including both natives and immigrants are warranted... - Difficulties in the diagnosis of HTLV-2 infection in HIV/AIDS patients from Brazil: comparative performances of serologic and molecular assays, and detection of HTLV-2b subtypeHelena Kaminami Morimoto
Departamento de Patologia, Análises Clínicas e Toxicológicas, Centro de Ciencias da Saude, Universidade Estadual de Londrina, Parana, Brasil
Rev Inst Med Trop Sao Paulo 49:225-30. 2007..These results emphasize the need of improving serologic tests for detecting truly HTLV-2 infected patients from Brazil, and confirm the presence of HTLV-2b subtype in the South of this country... - Potential impact of AUSFTA on Australia's blood supply. CommentWolfgang Frenzel
Med J Aust 186:427-8; author reply 430. 2007 - Human T-cell lymphotropic virus types I and II (HTLV-I and -II) infection among seroindeterminate cases in ArgentinaCarolina A Berini
Centro Nacional de Referencia para el SIDA, Departamento de Microbiologia, Parasitología e Immunología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina
J Med Virol 79:69-73. 2007..However, when seroreactivity to Env and Gag proteins are observed on the WB and especially in at-risk populations, HTLV infection should be suspected; such individuals should be followed-up and retested... - Evaluation of a new screening assay for HTLV-1 and -2 antibodies for large-scale useKerstin Malm
Department of Laboratory Medicine, Microbiology, Orebro University Hospital, 70185 Orebro, Sweden
J Med Virol 82:1606-11. 2010..Taken together, the overall specificity was 99.8%. The assay was sensitive, specific and appropriate for the large-scale screening of samples for HTLV-1/2 antibodies... - Antigenic mixture of synthetic peptides for the immunodiagnosis of HTLV I/II infectionYadaris Márquez Bocalandro
Department of Retroviruses, National Center for Scientific Research, Havana, Cuba
J Immunoassay Immunochem 25:205-14. 2004..The highest sensitivity and specificity was obtained with mixture 1, which could be very useful in the immunodiagnostic of HTLV infection... - Differential serological diagnosis of HTLV-I and HTLV-II infection by external membrane protein peptide-based enzyme immunoassaysH H Lee
Department of Haematology, University of Cambridge, UK
Clin Diagn Virol 8:9-16. 1997..It is critical to make a differential diagnosis of the two viruses... - [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires]J L Blejer
División Medicina Transfusional, Instituto de Cardiologia y Cirugia Cardiovascular, Buenos Aires, Argentina
Sangre (Barc) 40:447-51. 1995..This study could serve as a measure of the infection in the general population... - Detection of human T-lymphotropic virus type-I/II env antibodies by immunoassays using recombinant fusion proteinsD L Rudolph
Retrovirus Diseases Branch, Centers for Disease Control, Atlanta, Georgia 30333
Diagn Microbiol Infect Dis 17:35-9. 1993..We, therefore, conclude that although rEnv-93 is highly sensitive for detection of env protein, it has the potential to yield some false-positive reactions presumably due to the conserved nature of retroviral transmembrane epitopes... - Serological speciation of human T-cell leukaemia virus infections using synthetic peptide antigensJ H Tosswill
Virus Reference Division, Central Public Health Laboratory, London, England
J Med Virol 40:83-5. 1993..However, they should only be applied to sera that have been confirmed by Western blot or other methods as anti-HTLV-I/II positive. Even then they may fail to speciate sera from non-Japanese, non-Afrocaribbean populations... - Evaluation of two commercial human T-cell lymphotropic virus western blot (immunoblot) kits with problem specimensD Gallo
Viral and Rickettsial Disease Laboratory, State of California Department of Health Services, Berkeley 94704
J Clin Microbiol 32:2046-9. 1994..If all samples not reacting with this protein were interpreted as WB negative, regardless of other bands, the specificity would improve to 90% for CBC and 86% for DBL... - Human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis in São Paulo, BrazilR B Domingues
Department of Neurology, University of Sao Paulo School of Medicine, Brazil
Clin Infect Dis 20:1540-2. 1995..Despite the presence of HTLV-II virus in Brazil, all patients whose serum was tested by PCR were found to be infected with the HTLV-I virus... - Frequent detection of antibodies against HTLV antigens in patients with AIDS-related non-Hodgkin lymphomaG Zehender
Clinica delle Malattie Infettive, University of Milan, Italy
AIDS Res Hum Retroviruses 11:823-7. 1995..These data suggest that HTLV-II or a closely homologous retrovirus infects a high proportion of patients with AIDS-associated NHL... - Isolation of human T-cell lymphotropic virus type 2 from Guaymi Indians in PanamaM D Lairmore
Retrovirus Disease Branch, Centers for Disease Control, Atlanta, GA 30333
Proc Natl Acad Sci U S A 87:8840-4. 1990.... - Serological discrimination between HTLV-I and HTLV-II antibodies by ELISA using synthetic peptides as antigensY Washitani
Fukuoka Red Cross Blood Center, Japan
Int J Cancer 49:173-7. 1991.... - Infectious transmission of human T-cell lymphotropic virus type II in rabbitsG L Cockerell
Department of Pathology, Colorado State University, Fort Collins 80523
Blood 78:1532-7. 1991..These results provide the first evidence of HTLV-II infection in a species other than humans, and demonstrate the usefulness of the rabbit as an animal model to study the biologic response to different isolates of this human retrovirus... - Identification of immunodominant epitopes in envelope glycoprotein of human T lymphotropic virus type IIR B Lal
Retrovirus Diseases Branch, Centers for Disease Control, Atlanta, Georgia 30333
Virology 186:274-9. 1992..We conclude that peptides Env-20(85-102) and Env-202(173-209) represent the type-specific immunodominant epitopes of HTLV-II external glycoprotein... - Antibody to human retroviruses among drug users in three east coast American cities, 1972-1976R J Biggar
Viral Epidemiology Section, National Cancer Institute, Bethesda, Maryland 20852
J Infect Dis 163:57-63. 1991..Therefore, HTLV (probably HTLV-II) has been a common infection of drug users for many years but adverse outcomes following infection were not demonstrated... - Human T-cell leukemia virus type-I/II (HTLV-I/II) serologic testing: the importance of assaying for the full complement of viral antigensD M Aboulafia
Department of Medicine, Virginia Mason Medical Center, Seattle, Washington
Viral Immunol 5:105-11. 1992..Current HTLV-I/II ELISA kits may yield false negative results. Additional research into the development of rapid detection cost-efficient assays that test for the full compliment of viral antigens is needed... - Human T lymphotropic virus types I- and II-specific antibody-dependent cellular cytotoxicity: strain specificity and epitope mappingX Q Zhang
Infectious Disease Division, University of Colorado Health Sciences Center, Denver 80262
J Infect Dis 165:805-12. 1992.... - Sensitivity and specificity of a recombinant transmembrane glycoprotein (rgp21)-spiked western immunoblot for serological confirmation of human T-cell lymphotropic virus type I and type II infectionsR B Lal
Retrovirus Diseases Branch, Center for Disease Control, Atlanta, Georgia 30333
J Clin Microbiol 30:296-9. 1992..Thus, specimens exhibiting reactivity with rgp21 in the absence of reactivity with native gp46 and/or gp61/68 by Western blot should be tested further by a radioimmunoprecipitation assay to verify HTLV type I or type II infection... - Health care worker exposure to HIV-1 and HTLV I-II in critically ill, resuscitated emergency department patientsC Lewandowski
Department of Emergency Medicine, Henry Ford Hospital, Detroit, Michigan
Ann Emerg Med 21:1353-9. 1992..The purpose was to determine the seroprevalence of HIV-1 and HTLV I-II in patients undergoing ED resuscitations, the magnitude of health care worker exposure, and risk factors associated with infection... - Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, BrazilA A Segurado
Department of Infectious Diseases, School of Medicine, University of Sao Paulo, Brazil
Am J Trop Med Hyg 57:142-8. 1997.... - Detection of HTLV-I in clinical specimensM A Beilke
Section of Infectious Diseases, Tulane University School of Medicine, New Orleans, LA 70112
J Virol Methods 40:133-44. 1992..This review summarizes the techniques currently in use to screen for HTLV-I/II antibodies, as well as methods to detect viral genome and/or gene products in blood and tissue specimens... - Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patternsA M Mangano
, , Buenos Aires, Argentina
J Med Virol 74:323-7. 2004..However, seroreactivity to env proteins, in particular to GD21, may indicate infection and a follow-up study of each seroreactive blood donor should be considered... - Is seroprevalence of HTLV-I/II among blood donors in Lebanon relevant?Hala Tamim
Department of Epidemiology and Biostatistics, Faculty of Health Sciences, American University of Beirut Medical Center, Beirut, Lebanon
Am J Infect Control 32:220-3. 2004.... - Detection of human T-lymphotropic virus (HTLV) tax sequences in New York City blood donors seronegative for HTLV types 1 and 2Charlene S Dezzutti
Division of AIDS, STD, and TB Laboratory Research, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Clin Diagn Lab Immunol 10:715-7. 2003..All NYBD tested negative for antibodies to HTLV types 1 and 2 and HTLV Tax. HTLV tax sequences were not detected in the NYBD lymphocytes. These data demonstrate the lack of HTLV-1 tax in this group of NYBD at low risk for HTLV infection... - [Absence of HTLV-I/II virus circulation in blood donors from the provinces of Santa Fe and Santiago del Estero]R Gastaldello
, , Facultad de Medicina, , Av. Enfermera Gordillo Gomez s/n, Ciudad Universitaria, , Argentina
Rev Argent Microbiol 34:107-9. 2002..These results suggest that HTLV-I/II are not circulating in low risk populations in these provinces or that the prevalences of infection would be lower than that reported by blood banks in other provinces of Argentina... - [The prevalence of serum IgG antibodies against HTLV viruses type I and II in sarcoidosis patients]Alicja Sieminska
Katedry i Kliniki Chorób Płuc i Gruźlicy AM w Gdańsku
Pneumonol Alergol Pol 70:52-7. 2002..213; thus, no positive results of the test were observed. The values of OD did not differ significantly in both groups (p = 0.59). CONCLUSION: In our region the participation of HTLV-I in the pathogenesis of sarcoidosis is doubtful... - Strategies for diagnosis of HTLV-I and -IIRigmor Thorstensson
Department of Immunology, Swedish Institute for Infectious Disease Control, Solna, Sweden
Transfusion 42:780-91. 2002..No gold standard exists for diagnosis of HTLV infection. The aim of thus study was to compare the accuracy of a combination of two sensitive ELISAs with Western blot (WB), a line immunoassay, and PCR for diagnosis of HTLV infection... - Screening for viral markers in volunteer and replacement blood donors in West AfricaF Sarkodie
Blood Service, Department of Medicine, Komfo Anokye Teaching Hospital, Kumasi, Ghana
Vox Sang 80:142-7. 2001..No p24 antigen-positive/anti-HIV-negative donations were found. The prevalence of HTLV-I/II was generally low (0.5%). CONCLUSION: All blood donations should be screened for hepatitis B virus (HBV), HIV and HCV markers... - High prevalence of simian T-lymphotropic virus type L in wild ethiopian baboonsTaichiro Takemura
Institute for Virus Research, Kyoto University, Kyoto 606 8507, Japan
J Virol 76:1642-8. 2002..Further studies are required to know if STLV-L is spreading into human populations... - Chimeric synthetic peptides from the envelope (gp46) and the transmembrane (gp21) glycoproteins for the detection of antibodies to human T-cell leukemia virus type IIM Hernández Marin
Department of Peptide Synthesis, Immunoassay Center, Havana, Cuba
Biochem Biophys Res Commun 289:7-12. 2001..Those results may be related to a higher peptide adsorption capacity to the solid surface and for epitope accessibility to the antibodies. This chimeric peptide would be very useful for HTLV-II diagnostic... - Immunofluorescence assay reactivity patterns of serum samples presenting indeterminate Western blot results for antibodies to HIV-1 and HTLV-I/II in Cordoba, ArgentinaR Gastaldello
Institute of Virology Dr J M Vanella, Faculty of Medical Science, National University of Cordoba, Cordoba, Argentina
Rev Inst Med Trop Sao Paulo 43:277-82. 2001..Finally, this study shows the potential usefulness of IFA in elucidating the status of HIV-1 and HTLV-I/II infection of individuals with indeterminate Wb profiles, thus enabling resolution of retrovirus infection status... - Seroprevalence of specific viral infections in confiscated orangutans (Pongo pygmaeus)K S Warren
Wanariset Orangutan Reintroduction Centre, East Kalimantan, Indonesia
J Med Primatol 27:33-7. 1998..The results confirm the importance of quarantine and the need for diagnostic differentiation of virus infections to determine if they are of human origin or unique orangutan viruses... - HTLV-I in Northeast Brazil: differences for male and female injecting drug usersI Dourado
Instituto De Saude Coletiva, Salvador, Bahia, Brazil
J Acquir Immune Defic Syndr Hum Retrovirol 19:426-9. 1998..To investigate the seroprevalence of HTLV-I infection among male and female injecting drug users (IDUs)... - Evidence among blood donors for a 30-year-old epidemic of human T lymphotropic virus type II infection in the United StatesE L Murphy
Department of Laboratory Medicine, UCSF Box 0884, San Francisco, CA 94143, USA
J Infect Dis 180:1777-83. 1999..These data are consistent with a 30-year-old epidemic of HTLV-II in the United States due to injection drug use and secondary sexual transmission and with an apparent West Coast focus... - A seroepidemiological survey of HTLV-I/II carriers in the Puna JujeñaJ E Dipierri
Instituto de Biologia de la Altura, Universidad Nacional de Jujuy, Argentina
Medicina (B Aires) 59:717-20. 1999..This distribution is probably linked both to a history of prehistoric human dispersal in the Andes and to high mother- to-child transmission of the virus under close conditions of each group... - [Screening of donor blood for viral markers. Anti-HIV, HBsAg and anti-HTLV-I/II in Denmark 1990-1999]E Dickmeiss
H:S Rigshospitalet, klinisk immunologisk afdeling, og epidemiologisk afdeling, Statens Serum Institut,
Ugeskr Laeger 163:2623-8. 2001..The frequency of HTLV-I infection among candidate donors was 1 in 50,000 and that of HTLV-II infection 1 in 100,000. No seroconverters have been found... - [HTLV-I/II seroprevalence and risk factors associated with infection in a blood donor population in Córdoba, Argentina]S Gallego
Instituto de Virologia Dr J M Vanella, Facultad de Ciencias Medicas, Universidad Nacional de Cordoba, Argentina
Rev Argent Microbiol 33:182-6. 2001.... - Constitutive production of interleukin-6 and tumor necrosis factor-alpha from spontaneously proliferating T cells in patients with human T-cell lymphotropic virus type-I/IIR B Lal
Retrovirus Diseases Branch, Centers for Disease Control, Atlanta, GA 30333
Blood 78:571-4. 1991..None of the other cytokines (IL-1 beta, IL-2, IL-3, IL-4, and IFN-tau) were detectable in any of the culture. These data suggest that release of IL-6 and TNF-alpha may regulate lymphocyte proliferation in HTLV-I/II-infected individuals... - Evaluation of a combined lysate/recombinant antigen anti-HTLV-I/II ELISA in high and low endemic areas of HTLV-I/II infectionH Vrielink
Red Cross Blood Bank Amsterdam, The Netherlands
Transfus Med 5:135-7. 1995..In Ethiopia 55% of the HTLV-I/II WB-positive individuals were exclusively HTLV-II positive, whereas in Curaçao no HTLV-II infections were found... - Sensitivity of two enzyme-linked immunosorbent assay tests in relation to western blot in detecting human T-cell lymphotropic virus types I and II infection among HIV-1 infected patients from São Paulo, BrazilA Caterino de Araujo
Instituto Adolfo Lutz, , Brazil
Diagn Microbiol Infect Dis 30:173-82. 1998....